Isomorphic Labs AI drug-discovery funding and valuation talks

Mapped to your portfolio

Overview

Description Isomorphic Labs is seeking new funding at a potential $40 billion to $50 billion valuation to expand its AI drug-discovery platform. Overview Isomorphic Labs is in discussions with investors for a financing round to support its artificial intelligence platform for pharmaceutical research. The company is negotiating a…

Possible scenarios

42%Successful Mega-Round+0.2%
28%Valuation Negotiated Down-0.1%
18%Pharma Partnership Validation+0.2%

For information only. Not investment advice.

Stories in this saga

1 story, 1 source

Oct 8, 2026
AstraZeneca Strikes Up to $1.5 Billion AI Drug Discovery Deal With Insitro

Isomorphic Labs AI drug-discovery funding and valuation talks

Mapped to your portfolio

Overview

Possible scenarios

Stories in this saga

AstraZeneca Strikes Up to $1.5 Billion AI Drug Discovery Deal With Insitro

Portfolio

Portfolio

Possible scenarios

Mapped to your portfolio

Mapped to your portfolio

Overview

Possible scenarios

Keeping an eye on this saga?

Stories in this saga

AstraZeneca Strikes Up to $1.5 Billion AI Drug Discovery Deal With Insitro

Portfolio

Portfolio

Possible scenarios

Mapped to your portfolio